key: cord-0067575-vt8woseu authors: Golshani, Shiva; Ali Faramarzi, Mohammad title: Expected Impact of Biosimilars on the Pharmaceutical Companies date: 2021-09-03 journal: Iran J Med Sci DOI: 10.30476/ijms.2021.92314.2356 sha: d25ae7dca0e55785d5ff79de0c71f45bddf62c9b doc_id: 67575 cord_uid: vt8woseu nan long-term benefits of the product. 12 The biosimilar market is currently controlled by a number of issues such as patent expiration of biological drugs, lower prices, the rise of chronic diseases, and cost-saving policies by governments. Considering the above-mentioned topics, the market is expected to have a fast growth during 2021-2026. With the uncertainties in the state of COVID-19, the direct, as well as the indirect influences of the pandemic on different industries, should be also continuously evaluated. 13 Why biosimilar are important for patients An overview of biosimilars Biosimilars-why terminology matters What are biosimilars and are they important? European Union Biosimilars in the EU The Development Pathway for Biosimilar Biotherapeutics Biosimilars 2020 year in review None declared.